Systemic immune‐inflammation index, neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio can predict clinical outcomes in patients with metastatic non‐small‐cell lung cancer treated with nivolumab

BACKGROUND: Explore markers to predict the clinical outcomes of checkpoint inhibitors have high unmet needs. The following study investigates whether hematologic parameter such as systemic immune‐inflammation index (SII), neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR) is as...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jingjing, Li, Shuang, Zhang, Shuang, Liu, Ying, Ma, Lixia, Zhu, Jing, Xin, Ying, Wang, Ying, Yang, Changliang, Cheng, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805305/
https://www.ncbi.nlm.nih.gov/pubmed/31282096
http://dx.doi.org/10.1002/jcla.22964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805305/
https://www.ncbi.nlm.nih.gov/pubmed/31282096
http://dx.doi.org/10.1002/jcla.22964

Ejemplares similares